Bajaj Healthcare Ltd. Share Price

Bajaj Healthcare FY26 Revenue Grows 12.6% Profit Decline

💊

reported FY26 revenue of ₹611 crore, registering a 12.6% year-on-year increase and reflecting healthy growth in its core business. However, net profit declined 50.4% to ₹213 crore, primarily due to a ₹332 crore exceptional loss related to the reversal of previously recognised technical know-how income. The sharp impact from the exceptional item resulted in a significant decline in reported profitability despite strong revenue growth during the year. The contrasting performance highlights the importance of separating underlying operating performance from one-off accounting items when assessing the company's financial results. Investors will continue to monitor revenue growth, operating margins, core business performance and the company's ability to sustain profitability in FY27. The company’s future performance will also depend on how effectively it manages exceptional items and strengthens its underlying earnings base.

See More

🚨 Bajaj Healthcare Q1 Boosts Profit Growth — Stock in Focus Today!

reported a healthy Q1 performance with profit rising 14.1% YoY to ₹13.9 crore compared to ₹12.2 crore in the same quarter last year. Revenue also grew 11.3% YoY to ₹165.6 crore versus ₹148.8 crore, reflecting steady business momentum. 📊 Q1 Highlights ✔️ Profit: ₹13.9 Cr (+14.1% YoY) ✔️ Revenue: ₹165.6 Cr (+11.3% YoY) 📈 Recent Stock Performance • 1 Day: +2.90% • Last 5 Sessions: +10.88% • YTD: -9.44% • 1 Year: -25.76% With earnings growth and improving near-term momentum, Bajaj Healthcare is likely to remain on investors’ radar in today’s trading session. 📌 Disclaimer: This content is for information only and not investment advice. Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Please consult a SEBI-registered advisor before making any investment decisions.

See More

Bajaj Healthcare Q1 Performance: Robust Operational Growth and Return to Profitability

Bajaj Healthcare Ltd. has reported a strong performance for the quarter ended June 30, 2026. The pharmaceutical manufacturer—specializing in active pharmaceutical ingredients (APIs), formulations, and nutraceuticals—demonstrated solid year-over-year growth and successfully rebounded from a loss in the preceding quarter, driven by higher sales and expanded operating margins. Revenue from Operations: Grew by 11.3% to ₹165.6 crore, up from ₹148.8 crore in the corresponding quarter of the previous year. Net Profit (PAT): Consolidated Profit After Tax from continuing operations rose by 14.1% to ₹13.9 crore, compared to ₹12.2 crore last year. Operating Profit (EBITDA): Increased by 17.3% to ₹28.8 crore, up from ₹24.5 crore. EBITDA Margin: Expanded by 90 basis points to 17.4%, up from 16.5%, reflecting a clear improvement in operating profitability and cost efficiency. Sequential Recovery and Turnaround A central highlight for investors this quarter is the company's sequential recovery. Bajaj Healthcare posted a PAT of ₹13.9 crore against a net loss of ₹19.4 crore in the preceding March quarter. Revenue Momentum: Sequentially, revenue increased by 8.2% from ₹153.1 crore. Resolution of Exceptional Items: The March quarter's loss was heavily weighed down by a one-time exceptional expense of ₹33.2 crore. This was primarily due to the reversal of income recognized in an earlier period under a technical know-how arrangement, following delays caused by geopolitical instability in West Asia. The Q1 results indicate that the core business remains fundamentally sound absent these one-off geographical headwinds. Market Reaction Investors responded positively to the earnings beat and the return to profitability. Following the earnings announcement, shares of Bajaj Healthcare closed at ₹391 on the National Stock Exchange (NSE), registering a gain of 4.56% from the previous close.

See More

Q1 Results in Coming Week: From Infosys to

- Check full list of companies announcing June quarter results

Q1 Results in Coming Week: As the first-quarter earnings season for FY27 gathers pace, several companies are set to announce their June quarter results between July 20 and July 25. Investors will closely track earnings from Infosys, UltraTech Cement, Paytm, Adani Green Energy, Adani Power, Nestlé India, BPCL, IndusInd Bank, Bajaj Auto, Tata Consumer Products and several other companies across the banking, financial services, IT, auto, energy, cement and consumer sectors for cues on corporate performance and market direction. Q1 Results - July 20-25 July 20 - Bajaj Healthcare, BlueStone Jewellery and Lifestyle, Canara HSBC Life Insurance Company, Indian Overseas Bank, Jaiprakash Power Ventures, One 97 Communications (Paytm) and UltraTech Cement are among major companies which will announce their quarterly earnings performance on July 20.

See More

Bajaj Hindusthan Sugar Focuses on Ethanol Expansion and Integrated Sugar Operations

Bajaj Hindusthan Sugar continues to strengthen its integrated business through sugar manufacturing, ethanol production, and power co-generation. The company stands to benefit from India's ethanol blending programme, improving demand for renewable fuels, and supportive policy initiatives. Expansion in distillery capacity and operational efficiencies remain key focus areas, while investors continue to monitor sugar realizations, ethanol volumes, cane availability, debt reduction, cash flow generation, and profitability. The pace of deleveraging and execution of capacity expansion will remain important indicators of the company's long-term operational performance. Disclaimer: Investments in securities are subject to market risks. This content is for educational purposes only and should not be construed as investment advice or a recommendation to buy, sell, or hold any security.

See More